Mannitol.
A sugar alcohol used to sweeten chewable supplements without spiking your blood sugar. Sweetens chewable supplements and provides good tablet compressibility for manufacturing.
Reviewed March 2026
- Category
- General
- Also filed under
- Low glycemic sweetenerGood mouthfeel in chewable tablets
What Mannitol is, and what it does.
- Does it work
- Better sweetener than sugar for supplements. Still just an excipient.
- How much to take
- Not something you dose. Present for taste and manufacturing.
- Time to feel it
- It's a sweetener and tablet ingredient rather than an active, so it has no onset of its own. What lands right away is sweetness and a cooling feel on the tongue.
- The first dose
- Sweet taste in chewable tablets. No health effect.
- With regular use
- Nothing accumulates. Over weeks it stays a sweetener, and the measured effect of steady use sits in the mouth, where plaque pH holds steady because oral bacteria can't ferment it to acid.
- How well tolerated
- Well tolerated at supplement amounts. Laxative effect above 10-20g.
- How it feels
- Clean, sweet taste with a cooling sensation in chewable tablets.
- The overlooked benefit
- Mouth bacteria can't ferment it into acid the way they do sugar, so plaque pH holds steady. That's why it turns up in chewables and lozenges you keep in the mouth.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
- Low glycemic impact
- Non-cariogenic
Questions people ask about Mannitol.
- Will it upset my stomach?
- Not at supplement amounts (typically under 1g). The laxative effect requires 10-20g, which is way more than any chewable tablet contains.
- Is it better than sugar in supplements?
- For diabetics and dental health, yes. Lower glycemic impact and doesn't promote cavities.
- Is mannitol the same as sorbitol?
- Similar (both sugar alcohols) but different molecules. Mannitol has a cooler taste and better compressibility for tablets. Sorbitol is sweeter but stickier.
- Why does my chewable vitamin have a cooling sensation?
- That's the mannitol. Sugar alcohols absorb heat when they dissolve, creating a mild cooling effect on your tongue.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Steviol glycosides are used at milligram levels and cannot fill a serving on their own. Mannitol supplies the bulk, mouthfeel and cooling effect while contributing little digestible carbohydrate.
Mogrosides are intensely sweet at tiny doses, so a bulking sugar alcohol is needed to build the powder. Mannitol also masks part of the lingering aftertaste.
Both are poorly absorbed solutes that hold water in the bowel lumen by osmosis. Taken together the water-retaining effect adds up and looseness comes on at lower doses of each.
Mannitol that escapes absorption and inulin both reach the colon, where fermentation raises gas and osmotic water. The gut comfort threshold for the pair is lower than for either alone.
FOS is rapidly fermented in the proximal colon while unabsorbed mannitol adds osmotic water to the same segment. Combining them in one serving stacks the bloating and looseness threshold.
Polydextrose supplies low-calorie bulk with little sweetness, and mannitol supplies bulk with mild sweetness and a cooling effect. Formulators pair them to hit texture targets, and both add osmotic load in the lower gut.
Sorbitol is the stereoisomer of mannitol and behaves the same way in the gut: incompletely absorbed, osmotically active in the lumen and fermented in the colon. Products often carry both because they crystallise and taste differently. Their gastrointestinal effects add, so total polyol load is what matters rather than the individual figure.
Xylitol is a five-carbon polyol that shares mannitol's incomplete small intestinal absorption and its resistance to fermentation by oral bacteria. Confectionery and chewable formats blend them for sweetness and cooling effect. The osmotic load from the two adds together.
Erythritol differs from mannitol in one important respect: it is largely absorbed in the small intestine and excreted unchanged in urine, so less reaches the colon. Blending the two spreads the osmotic load rather than concentrating it. This is a formulation choice with a clear physiological basis.
Psyllium is a gel-forming fibre that holds water in the lumen without being appreciably fermented, while mannitol draws water osmotically and is fermented. Together they change stool water by two different routes. The pairing is common in bowel-regularity formats.
Partially hydrolysed guar gum ferments slowly and more distally than most polyols, which is why it is chosen where gas production is a concern. Combined with mannitol, the fermentation profile is spread across a longer stretch of colon. This is formulation reasoning rather than a measured pairing.
Colonic bacteria are what metabolise the mannitol that escapes small intestinal absorption, and several lactic acid bacteria both consume and produce mannitol in their own metabolism. The composition of a person's microbiota therefore shapes how much gas a given dose generates. The dependency runs from the polyol to the microbe.
Yeasts including Saccharomyces species use polyols such as mannitol as osmolytes and carbon sources under stress conditions. A live yeast preparation taken alongside mannitol meets a substrate it can use. The relevance to what happens in a human colon has not been established.
Glucomannan is a viscous konjac polysaccharide that slows gastric emptying and gut transit, while mannitol speeds transit by holding water in the lumen. In a shared formula the two act against each other on transit. Name the intent before combining them.
No human enzyme hydrolyses mannitol, and supplemental amylases, proteases and lipases do not act on it either, so an enzyme blend does not change how much is absorbed. What enzymes can change is the digestion of other components of the same meal, which alters how much osmotic material arrives together. Read the pairing as unrelated on mannitol itself.
Poorly absorbed magnesium salts hold water in the lumen by the same osmotic mechanism mannitol uses. Taken together the two loads add, and the gastrointestinal effect at a combined dose is larger than either figure suggests alone. This matters most in powdered drink formats where both are present.
Sodium bicarbonate at gram doses contributes its own osmotic and gas load to the gut, on top of the load from an unabsorbed polyol. Effervescent and sports formats often carry both. The combined gastrointestinal effect is the practical point.
Talk to a doctor before taking Mannitol if any of these apply to you: Can cause bloating or diarrhea in sensitive individuals at high doses. These are flags to check first, not effects Mannitol is known to cause.
Not medical advice. Show the label to your pharmacist.What Mannitol actually does.
Mannitol is a sugar alcohol made from mannose, and it's nearly identical to sorbitol, differing only in how one carbon atom is arranged.
The body has no enzyme that breaks mannitol down efficiently, so it's absorbed slowly and much of an oral dose reaches the colon unchanged.
Mannitol that isn't absorbed pulls water into the gut, which is why larger single doses can cause loose stools and bloating.
Gut bacteria ferment the unabsorbed mannitol into short chain fatty acids plus hydrogen and carbon dioxide gas, which is why breath hydrogen rises after a big dose.
Where Mannitol comes from.
Mannitol usually starts as sugar syrup made from starch. Hydrogen is added to the sugar with a metal catalyst, which turns it into a sugar alcohol. Because mannitol dissolves less easily than its close relative sorbitol, it can be crystallised out and separated. Some producers use bacteria to do the same conversion instead, and a small amount still comes from seaweed. The crystals are then dried and ground into whichever powder texture the product needs.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
Starch is hydrolysed to glucose and, for the fructose route, isomerised, giving a concentrated sugar syrup as the input to hydrogenation.
The syrup is hydrogenated under pressure over a nickel catalyst, which reduces the aldehyde or ketone group to an alcohol. Fructose gives a mixture of mannitol and sorbitol, glucose gives mostly sorbitol.
Nickel is filtered out, the liquor is deionised and decolourised over carbon, and mannitol is separated from sorbitol by fractional crystallisation because it is far less soluble in water.
Some mannitol is made instead by heterofermentative lactic acid bacteria that reduce fructose to mannitol, giving a route that avoids a metal catalyst.
Mannitol was historically extracted from the dried exudate of the manna ash and from brown seaweed, where it occurs at high concentration. This route survives at small scale.
Crystals are washed, dried and then milled, granulated or spray-dried into the specific particle grade the formulator specified.
Getting Mannitol from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- A multicentre retrospective cohort compared intravenous mannitol with furosemide for kidney protection during cisplatin chemotherapy. The setting is hospital intravenous administration, not oral supplement use, and the design is observational so it shows association rather than cause.Cohort study. Harimitsu et al., 2025 (Scientific Reports). PMID 41286042 ↗
- Food-grade osmolytes including mannitol were compared for their effect on yeast fermentation performance under salt stress, confirming mannitol acts as a compatible osmolyte in microbial systems.In vitro study. Sathaiah et al., 2026 (Microbiology Spectrum). PMID 41910135 ↗
These are the studies our verdict leans on, chosen from the 2 we read for Mannitol. The full linked list is below.
The studies, linked.
10 sources behind our Mannitol verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialTitrating Inhaled Steroid Dose Against Mannitol Hyper-responsiveness or BTS Outcomes: Comparative Effects on Asthma Exacerbations Over 1 YearClinicalTrials.gov ↗164 participants, Completed
- Clinical trialInternational, Multicentre, Double-blind, Placebo-controlled, Comparative, Randomized Study to Compare Efficacy and Safety of the Generic Drug BCD-063 (CJSC "BIOCAD", Russia) and Copaxone®-Teva ("Teva Pharmaceutical Industries Limited", Israel) in Patients With Relapsing-remitting Multiple SclerosisClinicalTrials.gov ↗Phase 3, 158 participants, Completed
- Clinical trialEffect of Edaravone on Radiation-induced Temporal Lobe Necrosis in Patients With Nasopharyngeal Carcinoma After RadiotherapyClinicalTrials.gov ↗Phase 2, 154 participants, Completed
- Clinical trialA Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of MZE001 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Healthy SubjectsClinicalTrials.gov ↗Phase 1, 121 participants, Completed
- Clinical trialRandomized Double-Blind Placebo-Controlled Phase 1, Safety and Immunogenicity Study of Two Dosages of Intranasal Norwalk Virus-like Particle Vaccine ( Norwalk VLP Antigen, MPL®, Chitosan, Mannitol, and Sucrose) Compared to Adjuvant/Excipients (MPL®, Chitosan, Mannitol, and Sucrose) and to Placebo (Empty DeviceClinicalTrials.gov ↗Phase 1, 61 participants, Completed
- Clinical trialEffect of Intravenous Administration of 20% Mannitol on the Optic Nerve Sheath Diameter(ONSD) in Patients With Raised Intracranial PressureClinicalTrials.gov ↗40 participants, Completed
- Clinical trialBlinded Cross-over Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic LeukemiaClinicalTrials.gov ↗Phase 1, 38 participants, Completed
- Clinical trialA Pilot Study to Investigate the Tolerability of Inhaled Dry Powder Mannitol (IDPM) Administered Via a Novel Dry Powder Inhaler Device in Healthy Individuals and Subjects With Bronchiectasis.ClinicalTrials.gov ↗Phase 1, 15 participants, Completed
- Clinical trialA Phase I/II Study of Patients With Newly Diagnosed Primary Central Nervous System Lymphoma Treated With Methotrexate/BBBD, and Adding Rituximab (an Anti CD-20 Antibody) and Carboplatin, to the Treatment RegimenClinicalTrials.gov ↗Phase 1, 81 participants, Unknown
- Clinical trialA Randomized, Open Label Clinical Trial of Sustained Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain InjuryClinicalTrials.gov ↗Phase 1, Withdrawn
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 19,634 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Mannitol is, not how risky it is. A report is not proof Mannitol caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
